The purpose of this systematic review is thus to assess the current available knowledge on impact of adjuvant chemotherapy and/or aromatase inhibitors in women with BC on metabolic alterations focusing on glucose and insulin metabolism. The gene discussed is CYP19A1; the disease is breast cancer.